Business Overview

BGC Group is the world's #2 interdealer broker (behind TP ICAP) attempting something no IDB has pulled off: transforming into an exchange company. The company operates one reportable segment — brokerage services — but internally tracks two business groupings that tell very different stories.

The legacy business is voice/hybrid OTC brokerage across rates, FX, credit, equities, and energy/commodities. Revenue: $2.70B (91.7% of total). This is 2,510 front-office brokers connecting institutional counterparties for commissions and matched principal spreads. It's relationship-driven, labor-intensive, and structurally commoditized. Voice/hybrid execution accounts for 81% of brokerage revenue. The April 2025 acquisition of OTC Global (≈$300M) made BGC the world's largest energy/commodities/shipping broker by revenue, adding $342M in Apr-Dec 2025 — but at 9.6% pretax margins vs. the core's 23.2%.

The growth business is Fenics — technology-driven platforms comprising 22.4% of revenue ($659.5M). Within Fenics, the highest-stakes asset is the FMX platform complex: FMX UST (cash U.S. Treasuries, 39% electronic CLOB market share), FMX Futures Exchange (SOFR and Treasury futures, 1% market share, launched Sep 2024), and FMX FX (spot and NDFs, $15.5B ADV). Ten bank equity partners (BofA, Barclays, Citi, Goldman, JPM, Morgan Stanley, Citadel Securities, Jump, Tower Research, Wells Fargo) invested $172M for 25.75% of FMX at a $667M post-money valuation, with an additional 10.3% subject to volume targets — creating a triple incentive: lower fees, equity upside, and margin savings.

Revenue by product (FY2025): ECS $911M (33.7%), Rates $794M (29.4%), FX $428M (15.9%), Credit $296M (11.0%), Equities $270M (10.0%). Geography: EMEA 52%, Americas 36%, APAC 12%. Customer concentration is low — top 10 at 23.6%, no single customer above 4%.

The unit economics tell the strategic story: $1.2M revenue per front-office employee (up from $1.0M in FY2024), with the highest-margin desks reclassified as "Fenics Integrated" once they cross 25% pretax margins. The commission share of brokerage has risen from 79.9% (FY2023) to 83.6% (FY2025), driven by OTC Global's commission-heavy model. Data, network, and post-trade revenue is $139M and growing at 9.5% — recurring, subscription-based, and capital-light.

Financial Profile

Four-Year Trajectory

The financial story has four layers.

Revenue acceleration is real but acquisition-inflated. The 30% FY2025 growth includes OTC Global ($342M in 9 months). Organic growth was ≈14.9% — strong for a brokerage, driven by FMX UST share gains, FX volume growth, and equities market activity. Fenics grew 15.5% to $659.5M. Fenics Growth Platforms (FMX UST, FMX FX, FMX Futures, Lucera, PortfolioMatch) hit $106.1M, growing 18.9%.

GAAP margins are misleading. GAAP pretax margin of 7.3% includes $329.6M in equity-based compensation (partnership units, RSUs), $64.2M restructuring charges, and $41.8M in loan forgiveness. Management's adjusted pretax margin was 21.3% in Q4 — 23.2% excluding OTC Global. The GAAP vs. adjusted gap creates a 4.8x P/E distortion (trailing GAAP P/E 28.8x vs. forward adjusted 6.0x). This gap is structural, not fraudulent — it reflects BGC's legacy partnership compensation model — but it screens poorly for quantitative investors.

Free cash flow is strong relative to GAAP earnings. FCF of ≈$328M on net income of $155M — a 2.1x ratio — reflects the non-cash nature of equity compensation. Capex intensity is just 2.2% of revenue ($66M), split between fixed assets ($21.5M) and capitalized software ($44.5M, primarily Fenics/FMX platform development). Working capital is volatile (-$243M in FY2025) due to matched principal transaction timing.

The balance sheet levered up materially. Net debt went from ≈$0 in FY2022-23 to ≈$955M. Total debt is $1.81B at 6.57% weighted average: $347M at 8.00% (2028), $500M at 6.60% (2029), $700M at 6.15% (2030), plus $240M drawn on a $700M revolver and $20M on a $400M Cantor bilateral facility. Interest expense is now $125.3M/year (4.3% of revenue), up 37.6% YoY. The maturity wall is 2028-2030. No near-term refinancing pressure, but the 8% 2028 notes will need addressing.

Capital allocation is aggressive and disciplined. FY2025: $282M buybacks (at 5-6x forward P/E), $281M M&A (OTC Global + AMCOM), $66M capex, $39M dividends. Share count declined 3.0% despite ongoing equity issuance. Sold kACE Financial for up to $119M ($80M upfront + $39M contingent) at 28x post-tax profits (per Abularrage on Q4 call) and Capitalab for ≈$46M — combined divestitures of ≈$165M (per Windeatt, Q4 call) on ≈$27M of annual revenue, harvesting low-growth Fenics assets at multiples far above the parent's 1.6x EV/revenue. Buyback authorization: $400M (re-approved Nov 2025).

A tension worth noting: Adjusted EBITDA declined 0.8% to $190.6M in Q4 despite 32% revenue growth — attributed by CFO Hauf to "charges related to the execution of the cost reduction program." Separately, GAAP income from operations included $54.8M of cost reduction charges. Revenue is growing but the cost structure is absorbing it in the near term — the margin expansion narrative depends on those restructuring charges being truly one-time.

Q1 2026 guidance: $860-920M adjusted revenue, $202-222M adjusted pretax earnings. Midpoint implies 23.8% adjusted pretax margin — up from Q4's 21.3%, suggesting OTC Global integration efficiencies beginning to flow.

Competitive Position

Where BGC is Winning

Cash U.S. Treasuries (FMX UST): This battle is effectively won. FMX UST holds 39-40% of the electronic CLOB market, having gained share in 12 of 13 consecutive quarters. Q4 ADV was $58.7B. CME's BrokerTec, the incumbent, saw Treasury ADV decline 5% YoY ($101.9B to $96.6B) per its own 10-K. Tradeweb's CLOB was down 6%. FMX UST clears through FICC — the same clearinghouse as BrokerTec — so the "foreign clearing" objection CME raises about FMX Futures does not apply here.

ECS Scale (#1 globally): Post-OTC Global, BGC is the world's largest energy/commodities/shipping broker by revenue ($911M). Product breadth spans crude, refined products, petrochemicals, natural gas, power, shipping/freight, metals, carbon, weather derivatives, and agriculture. Scale matters for counterparty access and cross-selling, but voice ECS brokerage is fundamentally commoditized — low switching costs, relationship-driven, thin margins.

Where BGC is Fighting

Interest Rate Futures (FMX Futures vs. CME): This is the multi-billion-dollar question. CME holds ≈99% of IR futures. FMX Futures launched SOFR futures in September 2024 and hit 1% market share in January 2026 (≈40K contracts ADV, ≈200K open interest). The structural proposition is different from previous exchange challengers:

1. LCH cross-margining: FMX clears through LCH, which holds $225B in interest rate swap margin via SwapClear. Firms can cross-margin FMX futures against their swap portfolios — a capability that did not previously exist. CME's cross-margining is futures-vs-cash-treasuries via FICC ($37B pool). These are fundamentally different propositions: FMX offers futures-vs-swaps (where institutional capital concentrates), CME offers futures-vs-cash.

2. Bank equity alignment: The 10 bank partners collectively route the majority of rates futures volume. They have equity incentive (25.75% + 10.3% earn-out), fee incentive (promotional pricing through summer 2026), and capital efficiency incentive (LCH cross-margining).

CME's response confirms the threat. For the first time, CME named "newly launched FMX Futures Exchange" in its FY2025 10-K competition section — alongside ICE, Cboe, and Euronext. CME launched BrokerTec Chicago (co-locating cash and futures, mimicking FMX's integrated model), received SEC approval for CMESC (securities clearing, to eventually offer unified cash/futures clearing), and expanded its FICC cross-margining arrangement. These are not cheap defensive moves.

Credit Sweep (PortfolioMatch): ≈20% of U.S. credit sweep market, ADV growing 68% YoY. Different protocol from MarketAxess (RFQ) or Tradeweb (multi-protocol) — passive algorithmic matching of offsetting flows. Niche but growing.

FX (FMX FX): ADV $15.5B (+40% YoY) in a $7.5T daily market. Growing fast but <1% share. Optionality, not a revenue driver yet.

What's Defensible vs. Commoditized

Defensible: FMX UST (network effects at 39% share), FMX Futures cross-margining (structural, not replicable by CME absent LCH swaps), Lucera network infrastructure (18 consecutive quarters of double-digit growth, deep API integration), Fenics Market Data (proprietary OTC pricing data), regulatory licenses across 26 countries.

Commoditized: Voice/hybrid brokerage (81% of brokerage revenue — broker leaves, takes clients), ECS voice (scale but no pricing power), commission rates (price competition).

Management & Governance

The Howard Lutnick Exit

Howard Lutnick — CEO since 1999, architect of Fenics, FMX, and the corporate conversion — was confirmed as U.S. Secretary of Commerce on February 18, 2025. He divested all holdings in BGC/Cantor/CFGM to trusts controlled by his son Brandon Lutnick (per ethics rules) on October 6, 2025.

Three Co-CEOs were appointed: Sean Windeatt (London-based COO veteran), John Abularrage (former Co-Head of Brokerage), and JP Aubin (former Co-Head of Brokerage). These are operators who ran the brokerage while Howard handled strategy and FMX. The 10-K risk factor acknowledges: "the loss of Mr. Howard Lutnick's deep institutional knowledge and industry relationships may impact our ability to meet our financial and operational goals."

Control Structure

Dual-class: 363.2M Class A shares (1 vote each, public float) and 109.5M Class B shares (10 votes each, 100% held by Cantor/CFGM + Lutnick family). Total Lutnick voting control: ≈75%. BGC is a "controlled company" under Nasdaq rules and can exempt itself from majority-independent board requirements, though it has not done so to date.

Brandon Lutnick (≈30s) now controls Cantor, which controls BGC. At the November 2025 annual meeting, ≈35% of independent Class A votes were withheld for Brandon's board election — a significant governance protest buried in the 8-K vote tallies, masked by Class B dominance.

Board composition: 4 independent of 9 directors (44%). Five are executives or controlling family. The board is management-friendly. Minority shareholders have no effective lever.

Related Party Transactions

BGC pays Cantor $38.3M annually for administrative services (office space, support). Cantor has unlimited right to internally use BGC market data at no cost — a notable concession given BGC earns $139M from other data customers. A bilateral $400M credit facility exists at SOFR - 25bps. Neither BGC nor Cantor is required to offer corporate opportunities to the other (Cantor can compete with BGC). Key employees may split time between entities.

Insider Activity

No open market purchases (Code P) by any executive or director. The October 2025 Howard-to-Brandon transfer was ethics-mandated, not directional. CFO sold $286K (immaterial, likely tax-related). BGC repurchased $282M at 5-6x forward P/E at the corporate level, but corporate buybacks are capital allocation, not personal conviction. When executives see their stock at 6x forward P/E and believe it's worth 25x, the absence of personal buying is a signal — or at minimum, the absence of one.

Factor Profile

Factor regression (250-day OLS) reveals BGC trades as a capital markets broker, not an exchange.

Full model (SPY + KCE + MTUM + IWM + IWD):

• Idiosyncratic: 59.2% — below the 75% target
• KCE (capital markets sector): 44.5% of variance — dominant factor
• IWD (value): 12.1% — significant value loading
• Alpha: +3.9% annualized

Peer comparison (SPY + KCE model):

Pure exchanges (CME, MKTX, CBOE) trade 94-97% idiosyncratically — on their own fundamentals, uncorrelated with the capital markets sector. BGC's 44.5% KCE loading means it rises and falls with the sector. The factor profile shift and the multiple expansion are the same phenomenon: reclassification from broker to exchange would move idio from 59% toward 90%+.

VIX sensitivity is negligible despite BGC's vol-driven revenue model. Negative SPY beta when sector is controlled (-0.22) suggests BGC outperforms in market stress within the capital markets sector — consistent with brokerage volume spikes in volatility.

Edge-weighted exposure is 59.2%. The remaining 41% is unintentional sector beta where no informational advantage exists.

Forward Expectations Gap

What the Price Requires

At $9.50 / 5.97x forward P/E, the market requires BGC to remain a broker. Every exchange peer trades at 28-33x forward P/E — a 4-5x multiple gap. The 6x multiple implicitly prices: zero FMX Futures success, continued voice brokerage commoditization, permanent governance discount, and skepticism about adjusted earnings quality.

Forward consensus EPS of ≈$1.59 implies ≈35% growth over management's stated FY2025 adjusted EPS of $1.18 (per Windeatt, Q4 call). My bridge analysis confirms this is achievable without heroic assumptions — full-year OTC Global contribution, ≈14-15% organic growth, moderate margin improvement, and initial FMX Futures fees. An important tailwind: management guided FY2026 adjusted tax rate of 11-14% (vs. 31.4% GAAP effective rate in FY2025). This lower adjusted tax rate, if correct, mechanically boosts after-tax EPS and is likely already embedded in the $1.59 consensus.

The disconnect is in the multiple, not the earnings.

Identified Gaps

FMX Futures fee transition (summer 2026): Currently generating zero revenue. Two-year early adopter fee-free period expires approximately summer 2026 (per Abularrage, Q4 call: "the changes in the fee structure happened two years after the deal was signed... beginning of this summer"). Street models likely include minimal contribution. The dollar amount is small initially ($5-25M H2 run-rate), but the signal value is disproportionate — first revenue is proof of concept.

OTC Global margins: Currently 9.6% pretax vs. core 23.2%. Management targeting $25M+ annualized savings in 2026. If margins reach 15-20% vs. consensus gradual improvement, that's $0.03-0.06 EPS upside. But BGC has never integrated something this large.

Comp ratio normalization: FY2025 at 67.5% was inflated by OTC Global brokers, restructuring, and $41.8M loan forgiveness. If it normalizes to 64-65%, that's ≈$0.05-0.10 EPS uplift — the largest single margin variable.

Coverage barrier: Only 2 analysts (Piper Sandler, BofA Securities). Both bullish, targets $14.00-$15.00 (+52.6%). Many institutional mandates require minimum 3-5 analyst coverage. This is extreme for a $4.5B company.

Options-analyst disconnect: Analysts are 100% bullish. Options market shows P/C ratio 1.93 (bearish) with ATM IV of ≈60%, above the 52-week high range (expensive). Total options open interest is thin (≈9K contracts), which amplifies noise in the P/C ratio — but the bearish positioning is consistent across measures (volume P/C also elevated). Whether this reflects hedging of existing longs, institutional concern about event risk, or genuine directional pessimism, the options market is pricing uncertainty the two sell-side analysts don't capture.

Screening barrier: GAAP P/E of 28.8x makes BGC look expensive to quantitative screens. The adjusted P/E of 6x is invisible to most automated strategies. The dual-class structure excludes BGC from governance-sensitive mandates. Complex business model resists easy classification.

Management vs. Consensus

The major disconnect is on FMX Futures trajectory. Management says FMX Futures is "tracking ahead of where FMX UST was at the same stage" — and FMX UST now holds 39% market share. Consensus prices zero FMX Futures success. Management also aspires to "exchange-level margins" by 2028 (≈40%+); consensus models ≈24-25% gradual improvement. These are different worlds.

A necessary caveat on the FMX analogy: FMX UST succeeded by migrating electronic CLOB volume between similar platforms — BrokerTec had no structural switching costs beyond liquidity. FMX Futures faces a fundamentally harder problem: moving entrenched derivatives open interest from CME's ecosystem, where trillions in existing OI create deep liquidity, tight spreads, and netting benefits that compound over time. The cross-margining advantage is real, but the OI inertia problem is real too. Management's comparison is optimistic framing — the competitive dynamics are not equivalent.

Key Risks

FMX Futures stalls. 1% market share after 16 months is encouraging but doesn't prove the thesis. If volume fails to grow when promotional pricing ends in summer 2026, early adopters could reduce or withdraw activity. CME's liquidity flywheel (99% share = tightest spreads) is a powerful structural force. Historical base rate: new exchanges challenging established ones rarely capture >5-10% without structural catalysts. FMX has structural catalysts (cross-margining, bank alignment), but they are unproven at scale.

CME retaliates on pricing. CME could cut IR futures fees to eliminate FMX's cost advantage. CME's operating margins are 60%+ — it has enormous room to cut pricing and still be profitable. A pricing war would pressure FMX Futures economics before they generate meaningful revenue.

OTC Global integration fails. At 9.6% pretax margins, OTC Global is a 250bp drag on blended margins. If integration stalls — broker departures, client attrition, cost saves not realized — it remains a permanent margin diluter on a $450M+ annual revenue base.

Governance event. Brandon Lutnick controls ≈75% voting power. The Raskin investigation into tariff refund allegations (related to Howard Lutnick's Commerce role) has not triggered any 8-K disclosure, but headline risk is real. 35% Class A vote opposition signals institutional discomfort. Related party transactions (free Cantor market data, shared employees, corporate opportunity waiver) are governance discount factors.

GAAP earnings quality. The 4.8x gap between GAAP P/E (28.8x) and adjusted P/E (6.0x) reflects $329.6M in equity-based compensation, $64.2M restructuring, and $41.8M loan forgiveness. These are real economic costs — equity comp dilutes shareholders, forgivable loans are cash outflows. The adjusted earnings narrative requires investors to accept non-GAAP framing permanently. Additionally, OTC Global was excluded from management's assessment of internal control over financial reporting for FY2025 (10-K). OTC Global represents ≈12% of revenue. The 10-K states: "When OTC Global is included in our assessment, we may discover the need to implement additional effective internal controls." Until OTC Global is fully integrated into ICFR, financial reporting quality carries incremental risk.

Debt burden. $1.81B total debt at 6.57% average costs $125M/year in interest. The 8% 2028 notes ($347M) will need refinancing in the current rate environment. Net debt of ≈$955M is manageable at current earnings (≈2.5x EBITDA), but constrains financial flexibility for further M&A or investment.

Co-CEO instability. Three co-CEOs is historically unstable. Windeatt (London), Abularrage, and Aubin ran operations under Howard, but strategic vision and dealmaking were Howard's domain. The FMX Futures thesis requires continued strategic execution — competitive positioning against CME, regulatory navigation, bank partner relationship management — that is fundamentally different from operating a brokerage. There is no evidence the current co-CEOs can drive this next phase. If the troika fragments or can't agree on capital allocation, execution suffers.

Broker retention. Voice brokerage depends on human capital. Front-office headcount is 2,510. Broker departures take client relationships — a structural risk in any relationship-driven business. Forgivable loans ($153.8M net outflow FY2025) are retention tools, but expensive ones.

What to Watch

FMX Futures fee transition (summer 2026). The single most important near-term catalyst. Does volume hold when promotional pricing ends? Even modest fee revenue ($5-15M H2 run-rate) would be proof of concept. Watch Q3 2026 earnings (likely November 2026) for first disclosed FMX Futures revenue contribution.

FMX Futures market share trajectory. Monthly ADV and open interest data. Current: ≈40K contracts ADV, ≈200K OI. If this reaches 100K ADV / 500K OI by year-end 2026, the flywheel is starting. If it stagnates at 40K, the thesis weakens.

OTC Global margin convergence. Q1 2026 guidance implies 23.8% blended adjusted pretax margin — up from 21.3% in Q4. If this holds or improves, OTC Global margins are converging. If blended margins fall back below 21%, integration is struggling.

Comp ratio. 67.5% in FY2025. Direction matters more than level. If it drops below 66% by H2 2026, margin expansion is real. If it stays elevated, OTC Global's labor-intensive model is structurally resistant to efficiency gains.

CME pricing response. Any fee reductions on SOFR futures or Treasury futures would signal competitive escalation. CME's February 2, 2026 pricing changes (8-K, Special Executive Report 9676) deserve monitoring — the specific products affected were not disclosed in the filing.

Analyst coverage expansion. If a third or fourth analyst initiates coverage, it removes an institutional ownership barrier and potentially catalyzes buying from funds with coverage minimums.

Brandon Lutnick governance actions. Any changes to related-party agreements, board composition, or capital allocation philosophy. The corporate opportunity waiver means Cantor could theoretically compete with BGC — watch for new Cantor ventures that overlap.

CME's CMESC launch. Expected "later in 2026." If CME successfully launches unified cash/futures Treasury clearing, it partially neutralizes FMX's clearing advantage narrative — though it cannot replicate the LCH swap cross-margining.

Credit organic growth. The only asset class declining organically (-1.8% constant currency in FY2025). If credit deteriorates further, it offsets gains elsewhere.

Evidence